<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To characterize the course of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) in terms of demographic indices (sex, age of <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo>), the presence of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and to ascertain a prognostic role of the disease exacerbations </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: A total of 121 LN patients were followed up from 1997 to 2004 (mean duration of the follow-up 5.6 +/- 6.4 years) </plain></SENT>
<SENT sid="2" pm="."><plain>A <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> course was characterized by the presence of a complete or partial remission, exacerbation of the disease, repeated hospitalisations </plain></SENT>
<SENT sid="3" pm="."><plain>Two types of exacerbations were considered: proteinuric, running with progressive <z:hpo ids='HP_0000093'>proteinuria</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> renal function (type 1); functional, running with elevation of blood <z:chebi fb="0" ids="16737">creatinine</z:chebi> (type 2) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Exacerbations were observed in one third of the examinees, 70% of them ran with <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Exacerbations occurred more frequently in males than in females (50 vs 27%, respectively; p = 0.08) and in patients with early <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> (at the age of 40 years and younger, 80 vs 60%, respectively; p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Exacerbations of type 2 occurred in males, in patients with early <z:hpo ids='HP_0003674'>onset</z:hpo> of renal damage and in APS association </plain></SENT>
<SENT sid="7" pm="."><plain>It is shown that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> exacerbations, their incidence and type (a functional type) have a negative influence on renal survival of the patients </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Identification of groups of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> patients at high risk of exacerbations and unfavourable prognostic role of exacerbations dictates the necessity of due immunosuppressive therapy for maintenance of remission </plain></SENT>
</text></document>